Bakhoum, Samuel F.
Ngo, Bryan
Laughney, Ashley M.
Cavallo, Julie-Ann
Murphy, Charles J.
Ly, Peter
Shah, Pragya
Sriram, Roshan K.
Watkins, Thomas B. K.
Taunk, Neil K.
Duran, Mercedes
Pauli, Chantal
Shaw, Christine
Chadalavada, Kalyani
Rajasekhar, Vinagolu K.
Genovese, Giulio
Venkatesan, Subramanian
Birkbak, Nicolai J.
McGranahan, Nicholas
Lundquist, Mark
LaPlant, Quincey
Healey, John H.
Elemento, Olivier
Chung, Christine H.
Lee, Nancy Y.
Imielenski, Marcin
Nanjangud, Gouri
Pe’er, Dana
Cleveland, Don W.
Powell, Simon N.
Lammerding, Jan
Swanton, Charles
Cantley, Lewis C.
Article History
Received: 24 April 2017
Accepted: 6 December 2017
First Online: 17 January 2018
Competing interests
: L.C.C. owns equity in, receives compensation from, and serves on the board of directors and scientific advisory board of Agios Pharmaceuticals. He is also a founder of and receives laboratory support from Petra Pharmaceuticals. The other authors declare no competing financial interests.